{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T06:35:31Z","timestamp":1697610931158},"reference-count":42,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,4,4]],"date-time":"2002-04-04T00:00:00Z","timestamp":1017878400000},"content-version":"vor","delay-in-days":93,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2002,1]]},"abstract":"<jats:p>Changes in lipid and carbohydrate metabolism and in body composition associated with the most potent and effective therapies available are being reported with increasing frequency. These changes could potentially lead to increased risks of cardiovascular disease. Clinical trials set up to investigate new antiretroviral therapies need to explore the therapies' impact on these potentially serious adverse outcomes, at least in a subset of patients.<\/jats:p><jats:p>The measurements that are feasible to include for all patients clearly differ from those required by a metabolic substudy. We propose the following: firstly, a minimal set of parameters that should be included in all trials; secondly, a desirable set of parameters that should be included whenever possible; and thirdly, a list of exploratory measures that should be considered. These exploratory measures are classified by the different mechanisms for changes in body composition or weight: endocrinal, cardiovascular, sterol and chemokine\/cytokine pathways. Standardized instruments for evaluating patients' reports of body changes and potential methods for assessing the risk of cardiovascular disease are described. Minimum and desirable standards for methods of measurement are also proposed. The choice of parameters is based on expert clinical opinion. The experts consulted include investigators from four large ongoing clinical trials with substudies specifically designed to investigate lipid and carbohydrate metabolism and changes in body composition, together with standard parameters for measurement within individual mechanistic pathways. The parameters proposed should be kept under review as the body of knowledge about metabolic function and fat redistribution in HIV infection increases.<\/jats:p>","DOI":"10.1046\/j.1464-2662.2001.00099.x","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T10:53:10Z","timestamp":1027680790000},"page":"65-72","source":"Crossref","is-referenced-by-count":2,"title":["The evaluation of metabolic function and fat redistribution in clinical trials"],"prefix":"10.1111","volume":"3","author":[{"name":"Oversight Committee for the Evaluation of the Metabolic Complications of HAART","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,4]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199807000-00003"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11518-5"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11443-X"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)08468-2"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200105040-00005"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200002180-00001"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)06102-4"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199911120-00019"},{"key":"e_1_2_8_10_2","first-page":"187","article-title":"Techniques for the measurement of visceral fat: a practical guide","volume":"17","author":"Van Der Kooy K","year":"1993","journal-title":"Int J Obes Relat Metab Disord"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/dmr.5610040607"},{"key":"e_1_2_8_12_2","unstructured":"WardDJ DelaneyKM MoormanACet al.Description of lipodystrophy in the HIV Outpatient Study (HOPS).1st International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV.San Diego CA June 1999[AbstractO14]."},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1998.85.1.115"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/51.6.1106"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/69.6.1162"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1999.87.3.1163"},{"key":"e_1_2_8_17_2","unstructured":"HudsonJ FreundJ GriffithsMRet al.for the PIILR DEXA Group and Investigators.Importance of centralized assessment of dual\u2010energy X\u2010ray absorptiometry (DEXA) in multicentred studies of HIV\u2010associated lipodystrophy: the PIILR Study DEXA QA Programme.2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV.Toronto Canada October 2000[AbstractP28]."},{"key":"e_1_2_8_18_2","unstructured":"KissebahAH.Central obesity: measurement and metabolic effects.Diabetes Rev1997;5:8\u201320."},{"key":"e_1_2_8_19_2","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1152\/jappl.1996.81.6.2580","article-title":"Segmental body composition assessed by bioelectrical impedance analysis and DEXA in humans","volume":"81","author":"Bracco D","year":"1996","journal-title":"J Appl Physiol"},{"key":"e_1_2_8_20_2","doi-asserted-by":"crossref","unstructured":"SchwenkA BreuerP KremerG WardL.Clinical assessment of HIV\u2013associated lipodystrophy syndrome: bioelectrical impedance analysis anthropometry and clinical scores.Clin Nutr2001;20:243\u2013249.","DOI":"10.1054\/clnu.2001.0395"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.79.6.715"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117545"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0800554"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000177913"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.45.8.1010"},{"key":"e_1_2_8_26_2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2337\/diab.44.12.1386","article-title":"Decreased insulin secretion and increased insulin resistance are independently related to the 7\u2010year risk of NIDDM in Mexican\u2013Americans","volume":"44","author":"Haffner SM","year":"1995","journal-title":"Diabetes"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.7.1087"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.170.2.2911678"},{"key":"e_1_2_8_29_2","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1210\/jcem.82.9.4224","article-title":"Leptin and clinical medicine: a new piece in the puzzle of obesity","volume":"82","author":"Bray JA","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-14-1-72"},{"key":"e_1_2_8_31_2","first-page":"291","article-title":"The regulation of adipose tissue distribution in humans","volume":"20","author":"Bj\u00f6rntorp PA","year":"1996","journal-title":"Int J Obesity"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1995.tb44719.x"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199702273360907"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1320655"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-212-44021A"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.76.3.559"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90243-J"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.130.1.1727716"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02172087"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.41.2.S97"},{"key":"e_1_2_8_41_2","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/clinchem\/43.5.808","article-title":"Calculation of LDL\u2010cholesterol by using apolipoprotein B for classification of nonchylomicronemic dyslipemia","volume":"43","author":"Planella T","year":"1997","journal-title":"Clin Chem"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(00)00162-4"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1086\/317429"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1464-2662.2001.00099.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1464-2662.2001.00099.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T05:28:53Z","timestamp":1697520533000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1464-2662.2001.00099.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1046\/j.1464-2662.2001.00099.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1464-2662.2001.00099.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}